...in patients with SLE ... E-C4d levels, but not serum C4 levels, were associated with disease activity... Recent evidence suggests that measurement of the erythrocyte-bound complement activation ...
The identification of patients who are at risk of allograft loss following a diagnosis of antibody-mediated rejection (AMR) is important for therapeutic decision making, but is limited by a lack of ...
Levels of C4d and C4d/C4 associate with clinical and histopathological treatment response in proliferative lupus nephritis. Complement activation markers, particularly C4d and the C4d/C4 ratio, are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback